Johnson & Johnson’s baby shampoo samples failed quality tests conducted by Rajasthan, according to a public notice from the state’s drugs watchdog, findings that were rejected by the US drugmaker.
This comes just a few months after Indian authorities launched an investigation into J&J’s Baby Powder to see if it contains cancer-causing asbestos.
US healthcare major Johnson & Johnson (J&J) has landed in trouble yet again with Indian health regulators as its famous ‘No More Tears’ baby shampoo was found to have a cancer-causing substance in quality tests conducted by Drug Control Organisation of Rajasthan.
Two batches of the shampoo manufactured at J&J’s facility in Baddi, Himachal Pradesh, reportedly contained formaldehyde more than stated by the company.
The Rajasthan drug controller issued a notice on March 31 saying that shampoo bottles from these batches must be taken off the shelves. In the notice, the authority mentioned that particular samples are “not of standard quality”. It did not elaborate.
A J&J spokeswoman said that the results it received from the watchdog indicated that formaldehyde had been discovered in the samples.
Formaldehyde, used in making building materials, is a known carcinogen(Cancer Causing Chemical)
The two batches of the baby shampoo tested are due to expire in September 2021 and were manufactured at the company’s plant in the northern state of Himachal Pradesh, according to the watchdog’s notice.
On March 13, a United States jury had ordered Johnson & Johnson to pay $29 million (Rs 202 crore) to a woman diagnosed with cancer, who alleged that the asbestos in the firm’s talcum-powder-based products caused her diseases.
J&J’s is one of the most recognised foreign brands in the country and leads sales in the Indian baby and child toiletries market